1994
DOI: 10.1172/jci117261
|View full text |Cite
|
Sign up to set email alerts
|

Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency.

Abstract: We report an inborn error of the tricarboxylic acid cycle, fumarase deficiency, in two siblings born to first cousin parents. They presented with progressive encephalopathy, dystonia, leucopenia, and neutropenia. Elevation of lactate in the cerebrospinal fluid and high fumarate excretion in the urine led us to investigate the activities of the respiratory chain and of the Krebs cycle, and to finally identify fumarase deficiency in these two children. The deficiency was profound and present in all tissues inves… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

4
107
1
1

Year Published

2000
2000
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 141 publications
(113 citation statements)
references
References 31 publications
4
107
1
1
Order By: Relevance
“…In short, four FH-deficient fibroblast lines from patients with recessive FH deficiency were used-FH-1, homozygous for the E362Q mutation (Bourgeron et al, 1994); FH-2, homozygous for the Q376P mutation (Remes et al, 2004); FH-3 is a compound heterozygote with InsK477/ R233H (Loeffen et al, 2005); and FH-4 is a compound heterozygote with delV387 and Q386H changes in one allele, and P369S in the other (Maradin et al, 2006). (These lines were kind gifts from Pierre Rustin (Bourgeron et al, 1994), Jan Smeitink (Loeffen et al, 2005), Anne M Remes (Remes et al, 2004) and Ksenija Fumic´, Ivo Baric´ (Maradin et al, 2006).) The residual FH activities in these lines were o1% for FH-1, o0.5% for FH-2, 20% for FH-3 and 5% for FH-4 (Bourgeron et al, 1994;Remes et al, 2004;Loeffen et al, 2005;Maradin et al, 2006).…”
Section: Cellsmentioning
confidence: 99%
“…In short, four FH-deficient fibroblast lines from patients with recessive FH deficiency were used-FH-1, homozygous for the E362Q mutation (Bourgeron et al, 1994); FH-2, homozygous for the Q376P mutation (Remes et al, 2004); FH-3 is a compound heterozygote with InsK477/ R233H (Loeffen et al, 2005); and FH-4 is a compound heterozygote with delV387 and Q386H changes in one allele, and P369S in the other (Maradin et al, 2006). (These lines were kind gifts from Pierre Rustin (Bourgeron et al, 1994), Jan Smeitink (Loeffen et al, 2005), Anne M Remes (Remes et al, 2004) and Ksenija Fumic´, Ivo Baric´ (Maradin et al, 2006).) The residual FH activities in these lines were o1% for FH-1, o0.5% for FH-2, 20% for FH-3 and 5% for FH-4 (Bourgeron et al, 1994;Remes et al, 2004;Loeffen et al, 2005;Maradin et al, 2006).…”
Section: Cellsmentioning
confidence: 99%
“…The FH gene on chromosome 1q42 encodes two isoenzymes, one in the cytosol and the other in the mitochondrial matrix (Bourgeron et al, 1994).…”
mentioning
confidence: 99%
“…Here we show that FH missense mutations significantly occurred in fully conserved residues and in residues functioning in the FH A-site, B-site, or subunit-interacting region. Of 24 distinct missense mutations, 13 In the autosomal dominant syndrome of multiple cutaneous and uterine leiomyomatosis (MCUL, Reed syndrome, leiomyomatosis cutis et uteri, multiple leiomyomatosis; OMIM 150800), affected females develop uterine leiomyomas and affected individuals of both sexes develop cutaneous leiomyomas. 1 Cutaneous leiomyomas are believed to be derived from the smooth muscle of the pilo-arrector apparatus.…”
mentioning
confidence: 99%
“…Clinical features of FHD include progressive encephalopathy, developmental delay, hypotonia, cerebral malformation and atrophy, and lactic and pyruvic acidemia with death usually occurring in infancy or by the first decade. [12][13][14][15] Thus this is an uncommon example of a situation in which heterozygous and homozygous mutations of a single gene give rise to very different phenotypes. The germline mutations of 11 FHD patients have been reported (Table 4).…”
mentioning
confidence: 99%
See 1 more Smart Citation